1. Home
  2. STVN vs LSCC Comparison

STVN vs LSCC Comparison

Compare STVN & LSCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • LSCC
  • Stock Information
  • Founded
  • STVN 1949
  • LSCC 1983
  • Country
  • STVN Italy
  • LSCC United States
  • Employees
  • STVN N/A
  • LSCC N/A
  • Industry
  • STVN Containers/Packaging
  • LSCC Semiconductors
  • Sector
  • STVN Consumer Discretionary
  • LSCC Technology
  • Exchange
  • STVN Nasdaq
  • LSCC Nasdaq
  • Market Cap
  • STVN 6.2B
  • LSCC 6.9B
  • IPO Year
  • STVN 2021
  • LSCC 1989
  • Fundamental
  • Price
  • STVN $22.96
  • LSCC $66.38
  • Analyst Decision
  • STVN Buy
  • LSCC Strong Buy
  • Analyst Count
  • STVN 4
  • LSCC 10
  • Target Price
  • STVN $25.13
  • LSCC $64.60
  • AVG Volume (30 Days)
  • STVN 341.4K
  • LSCC 3.1M
  • Earning Date
  • STVN 08-05-2025
  • LSCC 08-04-2025
  • Dividend Yield
  • STVN 0.27%
  • LSCC N/A
  • EPS Growth
  • STVN 6.78
  • LSCC N/A
  • EPS
  • STVN 0.57
  • LSCC 0.23
  • Revenue
  • STVN $1,344,798,591.00
  • LSCC $488,631,000.00
  • Revenue This Year
  • STVN $8.24
  • LSCC $3.92
  • Revenue Next Year
  • STVN $10.38
  • LSCC $19.45
  • P/E Ratio
  • STVN $40.05
  • LSCC $288.66
  • Revenue Growth
  • STVN 5.28
  • LSCC N/A
  • 52 Week Low
  • STVN $17.12
  • LSCC $34.69
  • 52 Week High
  • STVN $28.00
  • LSCC $70.55
  • Technical
  • Relative Strength Index (RSI)
  • STVN 47.98
  • LSCC 70.17
  • Support Level
  • STVN $21.51
  • LSCC $59.37
  • Resistance Level
  • STVN $23.72
  • LSCC $67.00
  • Average True Range (ATR)
  • STVN 0.84
  • LSCC 1.97
  • MACD
  • STVN 0.09
  • LSCC 0.17
  • Stochastic Oscillator
  • STVN 65.77
  • LSCC 91.87

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About LSCC Lattice Semiconductor Corporation

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.

Share on Social Networks: